Clinical Trial

Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk

Recruiting

Record status

This record was last updated September 25, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.

Summary

Patients with Type 1 Diabetes Mellitus (T1DM) have a higher risk of low-trauma (osteoporotic) fracture that is 7-12 times higher than non-diabetics. The bone density of people with Type 1 Diabetes is higher at the time of fracture than in non-diabetics. This suggests the presence of underlying bone tissue mechanical defects. The potential benefits to participants would be knowledge gained about their bone density and the results of laboratory tests. On a wider scale, there may be general benefits to society because the knowledge gained from this study may help better understand the effects of diabetes on bone health

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2023-01-17; most recent amendment 2024-09-23.

Trial Details

NCT Number	NCT05701254
Lead Sponsor	Creighton University
Conditions	Type 1 Diabetes, Osteopenia, Bone Loss, Fractures, Bone
Enrollment	80 participants
Start Date	2019-06-18
Primary Completion	2024-12 (estimated)
Study Completion	2025-01 (estimated)
Updated on ClinicalTrials.gov	2024-09-25